Ceramide in Lipid Emulsions Used in Parenteral Nutrition
- 4 March 2011
- journal article
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 35 (2) , 270-271
Abstract
Parenteral nutrition‐associated liver disease is a prevalent and severe complication of long term parenteral nutrition. We present here for the first time data on the presence of ceramide, a bioactive compound involved in a variety of metabolic processes, in different lipid emulsions used in parenteral nutrition. Further research is needed to determine whether this potential harmful bioactive compound is involved in parenteral nutrition‐associated liver disease.Keywords
This publication has 7 references indexed in Scilit:
- IL-6 Deficiency Attenuates Murine Diet-Induced Non-Alcoholic SteatohepatitisPLOS ONE, 2009
- ESPEN Guidelines on Parenteral Nutrition: Intensive careClinical Nutrition, 2009
- Fish Oil–Based Lipid Emulsions Prevent and Reverse Parenteral Nutrition–Associated Liver Disease: The Boston ExperienceJournal of Parenteral and Enteral Nutrition, 2009
- Principles of bioactive lipid signalling: lessons from sphingolipidsNature Reviews Molecular Cell Biology, 2008
- Short-Term Manipulation of Plasma Free Fatty Acids Does Not Change Skeletal Muscle Concentrations of Ceramide and Glucosylceramide in Lean and Overweight SubjectsThe Journal of Clinical Endocrinology & Metabolism, 2007
- Liver function and plasma antioxidant status in intensive care unit patients requiring total parenteral nutrition: comparison of 2 fat emulsionsJournal of Parenteral and Enteral Nutrition, 2004
- Choline deficiency induces apoptosis in primary cultures of fetal neuronsThe FASEB Journal, 2001